171 / 490
169
POSTERS AND ELECTRONIC POSTERS
| PROGRAMME AND EXHIBITION GUIDE
POSTERS
> Patient weight loss predicts worse overall survival for stage I lung cancer
treated with SABR
G. Cook (Canada), Y. Xu, P. Cross, O. Holmes, R. Macrae, J. Pantarotto
PO-0690
> SABR for central lung tumors: plan quality and long-term clinical
outcomes
H. Tekatli (The Netherlands), S. Senan, M. Dahele, B.J. Slotman,
W. Verbakel
PO-0691
> A novel endoscopically injected liquid-gel marker for image guided
radiotherapy of thoracic tumours
S.R. Mortensen (Denmark), J. Scherman-Rydhög, K.R. Larsen,
P.F. Clementsen, G.F. Persson, M. Aznar, M. Josipovic, P.M. Rosenschöld,
R.I. Jølck, T.L. Andresen, L. Specht
PO-0692
> Primary tumor response of locally advanced NSCLC in PET/CTs during
radiochemotherapy
T. Schimek-Jasch (Germany), S. Adebahr, M. Mix, A.L. Grosu, U. Nestle
PO-0693
> Lung toxicity modelling in thoracic post-operative RT for NSCLC and
pleural mesothelioma
A. Botticella (Belgium), G. Defraene, C. Billiet, C. Draulans, K. Nackaerts,
C. Deroose, J. Coolen, P. Nafteux, S. Peeters, D. De Ruysscher
PO-0694
> Lobectomy vs stereotactic ablative radiotherapy in NSCLC: a
multicentric series in four centers
V. Scotti (Italy), A. Bruni, G. Simontacchi, I.F. Furfaro, M. Loi, D. Scartoni,
A. Gonfiotti, D. Viggiano, C. De Luca Cardillo, B. Agresti, L. Poggesi,
E. Olmetto, K. Ferrari, M. Perna, P. Bastiani, L. Paoletti, L. Lastrucci,
P. Pernici, G. Carta, S. Borghesi, S. Bertocci, P. Giacobazzi, L. Voltolini,
L. Livi
PO-0695
Poster
CLINICAL TRACK: UPPER GI (OESOPHAGUS, STOMACH, PANCREAS,
LIVER)
> Prognostic impact of celiac/supraclavicular node metastasis in locally
advanced oesophageal cancer
W.K. Cho (Republic of Korea), D. Oh, Y.C. Ahn, H. Lee,
Y.M. Shim, J.I. Zo, J.M. Sun, M.J. Ahn, K. Park
PO-0696
> Neoadjuvant vs. adjuvant treatment of gastroesophageal junction
cancer: a retrospective analysis
A. Stessin (USA), J. Miccio, O. Oladeru, S. Ryu
PO-0697